AFRM vs LAB
Affirm Holdings Inc (AFRM) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. LAB currently screens at market cap $317.1M.
Not investment advice. Open the AFRM and LAB stock pages for the full models.
Not investment advice.